Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

NCT06267391 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

264

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Type2diabetes
Diabetes Mellitus, Type 2
Diabetes
Type 2 Diabetes

Interventions

DEVICE: ReCET Treatment
DEVICE: Sham Procedure

Sponsor

Endogenex, Inc.